This is a Cost Plus Fixed Fee contract awarded by the Centers for Disease Control and Prevention (CDC) to Vysnova Partners, LLC, a for-profit limited liability company, for a prospective, natural history study of SARS-CoV-2 infection in Wake Forest healthcare workers. The $54,179,237.36 contract was awarded on July 1, 2020 with a period of performance through February 28, 2023.
The original solicitation was Broad Agency Announcement number 75D301-20-R-67897, which sought white papers from offerors for applied research addressing the COVID-19 public health emergency across several topic areas, including surveillance and natural history of SARS-CoV-2 infections. The contract was not set aside for any particular business type.
Vysnova Partners, LLC is a firm that provides professional, scientific, and technical services to support medical research, clinical trials, disease surveillance, and global health initiatives for federal agencies. The company has significant experience supporting Department of Defense, Department of Health and Human Services, and other civilian agency programs, both domestically and internationally.
Generated 11/22/24, 9:54 AM